Axogen (FRA:LT3) Tariff Resilience Score: 6/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LT3 Axogen Inc FRA:LT3
64 GF Score
Price €33.02
GF Value €12.34
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Axogen Tariff Resilience Score?

Axogen FRA:LT3 -0.48% 64 Tariff Resilience Score is 6 as of Jul. 17, 2026. GuruFocus rates FRA:LT3 with a GF Score™ of 64/100 and a GF Value™ of €12.34 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 834 Medical Devices & Instruments companies, Axogen ranks better than 91.01% on this metric.

Axogen has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Axogen has Medical device company with some exposure to international supply chains. Tariffs could affect component costs, but strong domestic market presence and potential for alternative sourcing provide resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Axogen might have Average Resilient.

Axogen  (FRA:LT3) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Axogen Tariff Resilience Score Related Terms

FRA:LT3 vs TMDX, BFLY, ESTA: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Axogen's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Axogen Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Axogen's Tariff Resilience Score falls into.


FRA:LT3
64GF Score
Axogen Inc FRA:LT3
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Axogen (FRA:LT3) has a Tariff Resilience Score of 6 as of Jul. 17, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Axogen ranks #75 out of 834 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Axogen's Tariff Resilience Score too high?
Axogen's current Tariff Resilience Score is 6. Based on the distribution chart, Axogen ranks #75 out of 834 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Axogen has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Tariff Resilience Score compare to TMDX and BFLY?
According to the Medical Devices & Instruments industry distribution chart, Axogen ranks #75 out of 834 companies for Tariff Resilience Score. This places Axogen in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Axogen's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (FRA:LT3) is currently considered Significantly Overvalued. The stock's GF Value™ is €12.34, compared to a current price of €33.02 — trading 167.6% above its estimated fair value. The current Tariff Resilience Score is 6. Axogen's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Axogen (FRA:LT3), the current Tariff Resilience Score is 6 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (FRA:LT3) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be overvalued. The current stock price of €33.02 is trading 167.6% above its estimated GF Value™ of €12.34. GuruFocus considers Axogen to be Significantly Overvalued.

Key valuation signals for FRA:LT3:

  • Tariff Resilience Score: 6
  • GF Value™: €12.34 vs. price of €33.02 (167.6% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the FRA:LT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Other Exchanges AXGN:USA0HKD:UKLT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
64GF Score

Get the complete analysis for FRA:LT3

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€33.02
Price
€12.34
GF Value